company background image
A048410 logo

Hyundai Bioscience KOSDAQ:A048410 Stock Report

Last Price

₩14.26k

Market Cap

₩567.8b

7D

0.3%

1Y

-49.7%

Updated

06 Dec, 2024

Data

Company Financials

Hyundai Bioscience Co., Ltd.

KOSDAQ:A048410 Stock Report

Market Cap: ₩567.8b

A048410 Stock Overview

Operates as a biotechnology company. More details

A048410 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health4/6
Dividends0/6

Hyundai Bioscience Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Hyundai Bioscience
Historical stock prices
Current Share Price₩14,260.00
52 Week High₩29,100.00
52 Week Low₩12,650.00
Beta1.07
11 Month Change-17.90%
3 Month Change-27.91%
1 Year Change-49.70%
33 Year Change-47.38%
5 Year Change-0.28%
Change since IPO22.93%

Recent News & Updates

Hyundai Bioscience Co., Ltd.'s (KOSDAQ:048410) Stock Retreats 26% But Revenues Haven't Escaped The Attention Of Investors

Dec 05
Hyundai Bioscience Co., Ltd.'s (KOSDAQ:048410) Stock Retreats 26% But Revenues Haven't Escaped The Attention Of Investors

Is Hyundai Bioscience (KOSDAQ:048410) A Risky Investment?

Nov 12
Is Hyundai Bioscience (KOSDAQ:048410) A Risky Investment?

Recent updates

Hyundai Bioscience Co., Ltd.'s (KOSDAQ:048410) Stock Retreats 26% But Revenues Haven't Escaped The Attention Of Investors

Dec 05
Hyundai Bioscience Co., Ltd.'s (KOSDAQ:048410) Stock Retreats 26% But Revenues Haven't Escaped The Attention Of Investors

Is Hyundai Bioscience (KOSDAQ:048410) A Risky Investment?

Nov 12
Is Hyundai Bioscience (KOSDAQ:048410) A Risky Investment?

The Trends At Hyundai Bioscience (KOSDAQ:048410) That You Should Know About

Mar 14
The Trends At Hyundai Bioscience (KOSDAQ:048410) That You Should Know About

Is Hyundai Bioscience (KOSDAQ:048410) Using Too Much Debt?

Feb 07
Is Hyundai Bioscience (KOSDAQ:048410) Using Too Much Debt?

Imagine Holding Hyundai Bioscience (KOSDAQ:048410) Shares While The Price Zoomed 439% Higher

Jan 03
Imagine Holding Hyundai Bioscience (KOSDAQ:048410) Shares While The Price Zoomed 439% Higher

The Trends At Hyundai Bioscience (KOSDAQ:048410) That You Should Know About

Nov 29
The Trends At Hyundai Bioscience (KOSDAQ:048410) That You Should Know About

Shareholder Returns

A048410KR Personal ProductsKR Market
7D0.3%1.5%-1.4%
1Y-49.7%-9.6%-6.6%

Return vs Industry: A048410 underperformed the KR Personal Products industry which returned -8.2% over the past year.

Return vs Market: A048410 underperformed the KR Market which returned -4.9% over the past year.

Price Volatility

Is A048410's price volatile compared to industry and market?
A048410 volatility
A048410 Average Weekly Movement6.5%
Personal Products Industry Average Movement6.8%
Market Average Movement5.7%
10% most volatile stocks in KR Market11.7%
10% least volatile stocks in KR Market2.8%

Stable Share Price: A048410 has not had significant price volatility in the past 3 months compared to the KR market.

Volatility Over Time: A048410's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
200054Jong-Won Choiwww.hyundaibioscience.com

Hyundai Bioscience Co., Ltd. operates as a biotechnology company. The company provides Vitabrid C12, a vitamin C product that delivers active vitamin C into the skin. It develops Polytaxel, a drug for pancreatic cancer and solid tumors; and CP-COV03 drug for Covid 19.

Hyundai Bioscience Co., Ltd. Fundamentals Summary

How do Hyundai Bioscience's earnings and revenue compare to its market cap?
A048410 fundamental statistics
Market cap₩567.82b
Earnings (TTM)-₩10.44b
Revenue (TTM)₩15.82b

35.9x

P/S Ratio

-54.4x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A048410 income statement (TTM)
Revenue₩15.82b
Cost of Revenue₩3.81b
Gross Profit₩12.01b
Other Expenses₩22.45b
Earnings-₩10.44b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-262.18
Gross Margin75.90%
Net Profit Margin-66.00%
Debt/Equity Ratio57.6%

How did A048410 perform over the long term?

See historical performance and comparison